RBio is a leading company in the biotechnology, manufacturing, and pharmaceutical industries. Established in 1961, RBio is dedicated to following superior pharmaceutical production standards (GMP) and operates state-of-the-art cell therapy manufacturing facilities. The company specializes in stem cell therapy derived from adipose tissue and is at the forefront of technological advancements in treating rare and incurable diseases. RBio's commitment to advancing clinical trials and commercializing therapeutics for challenging medical conditions sets it apart in the industry.
There is no investment information
No recent news or press coverage available for RBio.
We care about your data, and we'd love to use cookies make your experience better.